A. Adegunsoye, J. M. Oldham, C. Bonham, C. Hrusch, P. Nolan et al., Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment: An Observational Cohort Study with Independent Validation, Am J Respir Crit Care Med, 2018.

D. Khanna, C. P. Denton, A. Jahreis, J. M. Van-laar, T. M. Frech et al., Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial, Lancet, vol.387, pp.2630-2640, 2016.

A. Ngom, P. Dumont, P. Diot, and E. Lemarié, Benign mediastinal lymphadenopathy in congestive heart failure, Chest, vol.119, issue.2, pp.653-659, 2001.

I. Marie, J. F. Gehanno, M. Bubenheim, A. B. Duval-modeste, P. Joly et al., Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature, Autoimmun Rev, vol.13, issue.2, pp.151-157, 2014.

C. J. Winterbottom, R. J. Shah, K. C. Patterson, M. E. Kreider, R. A. Panettieri et al., Exposure to Ambient Particulate Matter Is Associated With Accelerated Functional Decline in Idiopathic Pulmonary Fibrosis, Chest, vol.153, issue.5, pp.1221-1228, 2018.

S. Ronsmans and B. Nemery, The presence of autoimmune antibodies in pulmonary alveolar proteinosis does not necessarily imply idiopathic disease, Lancet Respir Med, vol.6, issue.9, p.48, 2018.